Transcriptional regulation of apoptosis

Essentials of Apoptosis: A Guide for Basic and Clinical Research

Volumn , Issue , 2009, Pages 239-260

  Dudgeon, Crissy ^a   Qiu, Wei ^a   Sun, Quanhong ^a   Zhang, Lin ^a   Yu, Jian ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Apoptosis; Bcl 2 family; Death receptors; Transcription factors

Indexed keywords

EID: 77951667457     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-60327-381-7_10     Document Type: Chapter

References (141)

1. Melino G, Lu X, Gasco M, et al. Functional regulation of p73 and p63: Development and cancer. Trends Biochem Sci 2003;28:663-70.
2. Moll UM, Slade N. p63 and p73: Roles in development and tumor formation. Mol Cancer Res 2004;2:371-86.
3. Vogelstein B, Lane D, Levine AJ. Surfing the p53 network. Nature 2000;408:307-10.
4. Vousden KH, Lu X. Live or let die: The cell's response to p53. Nat Rev Cancer 2002;2:594-604.
5. Yu J, Zhang L. The transcriptional targets of p53 in apoptosis control. Biochem Biophys Res Commun 2005;331:851-8.
6. Yu J, Zhang L, Hwang PM, et al. PUMA induces the rapid apoptosis of colorectal cancer cells. Mol Cell 2001;7:673-82.
7. Nakano K, Vousden KH. PUMA, a novel pro apoptotic gene, is induced by p53. Mol Cell 2001;7:683-94.
8. Oda E, Ohki R, Murasawa H, et al. Noxa, a BH3-only member of the BCL-2 family and candidate mediator of p53-induced apoptosis. Science 2000;288:1053-8.
9. Wu WS, Heinrichs S, Xu D, et al. Slug antagonizes p53-mediated apoptosis of hematopoietic progenitors by repressing puma. Cell 2005;123:641-53.
10. Miyashita T, Reed JC. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 1995;80:293-9.
11. Sax JK, Fei P, Murphy ME, et al. BID regulation by p53 contributes to chemosensitivity. Nat Cell Biol 2002;4:842-9.
12. Relaix F, Wei X, Li W, et al. Pw1/Peg3 is a potential cell death mediator and cooperates with Siah1a in p53-mediated apoptosis. Proc Natl Acad Sci USA 2000;97:2105-10.
13. Oda K, Arakawa H, Tanaka T, et al. p53AIP1, a potential mediator of p53-dependent apoptosis, and its regulation by Ser-46-phosphorylated p53. Cell 2000;102:849-62.
14. Okamura S, Arakawa H, Tanaka T, et al. p53DINP1, a p53-inducible gene, regulates p53-dependent apoptosis. Mol Cell 2001;8:85-94.
15. Miyashita T, Harigai M, Hanada M, et al. Identification of a p53-dependent negative response element in the BCL-2 gene. Cancer Res 1994;54:3131-5.
16. Sugars KL, Budhram-Mahadeo V, Packham G, et al. A minimal Bcl-x promoter is activated by Brn-3a and repressed by p53. Nucleic Acids Res 2001;29:4530-40.
17. Moroni MC, Hickman ES, Denchi EL, et al. Apaf-1 is a transcriptional target for E2F and p53. Nat Cell Biol 2001;3:552-8.
18. Harms K, Nozell S, Chen X. The common and distinct target genes of the p53 family transcription factors. Cell Mol Life Sci 2004;61:822-42.
19. Muller M, Wilder S, Bannasch D, et al. p53 activates the CD95 (APO-1/Fas) gene in response to DNA damage by anticancer drugs. J Exp Med 1998;188:2033-45.
20. Sheikh MS, Burns TF, Huang Y, et al. p53-dependent and -independent regulation of the death receptor KILLER/DR5 gene expression in response to genotoxic stress and tumor necrosis factor alpha. Cancer Res 1998;58:1593-8.
21. Liu X, Yue P, Khuri FR, et al. p53 up regulates death receptor 4 expression through an intronic p53 binding site. Cancer Res 2004;64:5078-83.
22. Lin Y, Ma W, Benchimol S. Pidd, a new death-domain-containing protein, is induced by p53 and promotes apoptosis. Nat Genet 2000;26:122-7.
23. Attardi LD, Reczek EE, Cosmas C, et al. PERP, an apoptosis-associated target of p53, is a novel member of the PMP-22/gas3 family. Genes Dev 2000;14:704-18.
24. Polyak K, Xia Y, Zweier JL, et al. A model for p53-induced apoptosis. Nature 1997;389:300-5.
25. Donald SP, Sun XY, Hu CA, et al. Proline oxidase, encoded by p53-induced gene-6, catalyzes the generation of proline-dependent reactive oxygen species. Cancer Res 2001;61:1810-5.
26. Hwang PM, Bunz F, Yu J, et al. Ferredoxin reductase affects p53-dependent, 5-fluorouracilinduced apoptosis in colorectal cancer cells. Nat Med 2001;7:1111-7.
27. Ellisen LW, Ramsayer KD, Johannessen CM, et al. REDD1, a developmentally regulated transcriptional target of p63 and p53, links p63 to regulation of reactive oxygen species. Mol Cell 2002;10:995-1005.
28. Gu Z, Flemington C, Chittenden T, et al. ei24, a p53 response gene involved in growth suppression and apoptosis. Mol Cell Biol 2000;20:233-41.
29. Wu GS, Saftig P, Peters C, et al. Potential role for cathepsin D in p53-dependent tumor suppression and chemosensitivity. Oncogene 1998;16:2177-83.
30. Bourdon JC, Renzing J, Robertson PL, et al. Scotin, a novel p53-inducible proapoptotic protein located in the ER and the nuclear membrane. J Cell Biol 2002;158:235-46.
31. Hermeking H. p53 enters the micro RNA world. Cancer Cell 2007;12:414-8.
32. Flores ER, Tsai KY, Crowley D, et al. p63 and p73 are required for p53-dependent apoptosis in response to DNA damage. Nature 2002;416:560-4.
33. Dobbelstein M, Strano S, Roth J, et al. p73-induced apoptosis: A question of compartments and cooperation. Biochem Biophys Res Commun 2005;331:688-93.
34. Melino G, Bernassola F, Ranalli M, et al. p73 induces apoptosis via PUMA trans activation and Bax mitochondrial translocation. J Biol Chem 2004;279:8076-83.
35. Terrinoni A, Ranalli M, Cadot B, et al. p73-alpha is capable of inducing scotin and ER stress. Oncogene 2004;23:3721-5.
36. Shinbo J, Ozaki T, Nakagawa T, et al. p73-dependent expression of DAN during cisplatin-induced cell death and osteoblast differentiation. Biochem Biophys Res Commun 2002;295:501-7.
37. Livera G, Petre-Lazar B, Guerquin MJ, et al. p63 null mutation protects mouse oocytes from radio-induced apoptosis. Reproduction 2008;135:3-12.
38. Gressner O, Schilling T, Lorenz K, et al. TAp63alpha induces apoptosis by activating signaling via death receptors and mitochondria. EMBO J 2005;24:2458-71.
39. Trink B, Osada M, Ratovitski E, et al. p63 transcriptional regulation of epithelial integrity and cancer. Cell Cycle 2007;6:240-5.
40. Eferl R, Wagner EF. AP-1: A double-edged sword in tum origenesis. Nat Rev Cancer 2003;3:859-68.
41. Shaulian E, Karin M. AP-1 as a regulator of cell life and death. Nat Cell Biol 2002;4:E131-6.
42. Kasibhatla S, Brunner T, Genestier L, et al. DNA damaging agents induce expression of Fas ligand and subsequent apoptosis in T lymphocytes via the activation of NF-kappa B and AP-1. Mol Cell 1998;1:543-51.
43. Kolbus A, Herr I, Schreiber M, et al. c-Jun-dependent CD95-L expression is a ratelimiting step in the induction of apoptosis by alkylating agents. Mol Cell Biol 2000;20:575-82.
44. Zhang X, Zhang L, Yang H, et al. c-Fos as a pro apoptotic agent in TRAIL-induced apoptosis in prostate cancer cells. Cancer Res 2007;67:9425-34.
45. Whitfield J, Neame SJ, Paquet L, et al. Dominant-negative c-Jun promotes neuronal survival by reducing BIM expression and inhibiting mitochondrial cytochrome c release. Neuron 2001;29:629-43.
46. Shaulian E, Schreiber M, Piu F, et al. The mammalian UV response: c-Jun induction is required for exit from p53-imposed growth arrest. Cell 2000;103:897-907.
47. Toh WH, Siddique MM, Boominathan L, et al. c-Jun regulates the stability and activity of the p53 homologue, p73. J Biol Chem 2004;279:44713-22.
48. Ivanov VN, Bhoumik A, Krasilnikov M, et al. Cooperation between STAT3 and c-Jun suppresses Fas transcription. Mol Cell 2001;7:517-28.
49. Rebollo A, Dumoutier L, Renauld JC, et al. Bcl-3 expression promotes cell survival following interleukin-4 deprivation and is controlled by AP1 and AP1-like transcription factors. Mol Cell Biol 2000;20:3407-16.
50. Janssens S, Tschopp J. Signals from within: The DNA-damage-induced NF-kappaB response. Cell Death Differ 2006;13:773-84.
51. Stevens C, La Thangue NB. The emerging role of E2F-1 in the DNA damage response and checkpoint control. DNA Repair (Amst) 2004;3:1071-9.
52. Dutta J, Fan Y, Gupta N, et al. Current insights into the regulation of programmed cell death by NF-kappa B. Oncogene 2006;25:6800-16.
53. Wang CY, Cusack JC Jr., Liu R, et al. Control of inducible chemoresistance: Enhanced anti-tumor therapy through increased apoptosis by inhibition of NF-kappa B. Nat Med 1999;5:412-7.
54. Johnson DG, Degregori J. Putting the oncogenic and tumor suppressive activities of E2F into context. Curr Mol Med 2006;6:731-8.
55. Stanelle J, Putzer BM. E2F1-induced apoptosis: Turning killers into therapeutics. Trends Mol Med 2006;12:177-85.
56. DeGregori J, Johnson DG. Distinct and overlapping roles for E2F family members in transcription, proliferation and apoptosis. Curr Mol Med 2006;6:739-48.
57. Wikonkal NM, Remenyik E, Knezevic D, et al. Inactivating E2f1 reverts apoptosis resistance and cancer sensitivity in Trp53-deficient mice. Nat Cell Biol 2003;5:655-60.
58. Stanelle J, Tu-Rapp H, Putzer BM. A novel mitochondrial protein DIP mediates E2F1- induced apoptosis independently of p53. Cell Death Differ 2005;12:347-57.
59. Li Z, Stanelle J, Leurs C, et al. Selection of novel mediators of E2F1-induced apoptosis through retroviral expression of an antisense cDNA library. Nucleic Acids Res 2005;33:2813-21.
60. Muller H, Bracken AP, Vernell R, et al. E2Fs regulate the expression of genes involved in differentiation, development, proliferation, and apoptosis. Genes Dev 2001;15:267-85.
61. Moroni MC, Hickman ES, Lazzerini Denchi E, et al. Apaf-1 is a transcriptional target for E2F and p53. Nat Cell Biol 2001;3:552-8.
62. Nahle Z, Polakoff J, Davuluri RV, et al. Direct coupling of the cell cycle and cell death machinery by E2F. Nat Cell Biol 2002;4:859-64.
63. Hershko T, Ginsberg D. Up-regulation of BCL-2 homology 3 (BH3)-only proteins by E2F1 mediates apoptosis. J Biol Chem 2004;279:8627-34.
64. Eischen CM, Packham G, Nip J, et al. BCL-2 is an apoptotic target suppressed by both c-Myc and E2F-1. Oncogene 2001;20:6983-93.
65. Croxton R, Ma Y, Song L, et al. Direct repression of the Mcl-1 promoter by E2F1. Oncogene 2002;21:1359-69.
66. Fortin A, MacLaurin JG, Arbour N, et al. The pro apoptotic gene SIVA is a direct transcriptional target for the tumor suppressors p53 and E2F1. J Biol Chem 2004;279:28706-14.
67. Phillips AC, Ernst MK, Bates S, et al. E2F-1 potentiates cell death by blocking anti apoptotic signaling pathways. Mol Cell 1999;4:771-81.
68. Nilsson JA, Cleveland JL. Myc pathways provoking cell suicide and cancer. Oncogene 2003;22:9007-21.
69. Hermeking H, Eick D. Mediation of c-Myc-induced apoptosis by p53. Science 1994;265:2091-3.
70. Sears R, Ohtani K, Nevins JR. Identification of positively and negatively acting elements regulating expression of the E2F2 gene in response to cell growth signals. Mol Cell Biol 1997;17:5227-35.
71. Mitchell KO, Ricci MS, Miyashita T, et al. Bax is a transcriptional target and mediator of c-Myc-induced apoptosis. Cancer Res 2000;60:6318-25.
72. Jeffers JR, Parganas E, Lee Y, et al. Puma is an essential mediator of p53-dependent and -independent apoptotic pathways. Cancer Cell 2003;4:321-8.
73. Fernandez PC, Frank SR, Wang L, et al. Genomic targets of the human c-Myc protein. Genes Dev 2003;17:1115-29.
74. Egle A, Harris AW, Bouillet P, et al. Bim is a suppressor of Myc-induced mouse B cell leukemia. Proc Natl Acad Sci USA 2004;101:6164-9.
75. Maclean KH, Keller UB, Rodriguez-Galindo C, et al. c-Myc augments gamma irradiation- induced apoptosis by suppressing Bcl-XL. Mol Cell Biol 2003;23:7256-70.
76. Eischen CM, Woo D, Roussel MF, et al. Apoptosis triggered by Myc-induced suppression of Bcl-X(L) or BCL-2 is bypassed during lymphomagenesis. Mol Cell Biol 2001;21:5063-70.
77. Shi Y, Glynn JM, Guilbert LJ, et al. Role for c-myc in activation-induced apoptotic cell death in T cell hy bridomas. Science 1992;257:212-4.
78. Green DR, Droin N, Pinkoski M. Activation-induced cell death in T cells. Immunol Rev 2003;193:70-81.
79. Brunner T, Kasibhatla S, Pinkoski MJ, et al. Expression of Fas ligand in activated T cells is regulated by c-Myc. J Biol Chem 2000;275:9767-72.
80. Kasibhatla S, Beere HM, Brunner T, et al. A "non-canonical" DNA-binding element mediates the response of the Fas-ligand promoter to c-Myc. Curr Biol 2000;10:1205-8.
81. You Z, Madrid LV, Saims D, et al. c-Myc sensitizes cells to tumor necrosis factor mediated apoptosis by inhibiting nuclear factor kappa B trans activation. J Biol Chem 2002;277:36671-7.
82. Burstein E, Duckett CS. Dying for NF-kappa B? Control of cell death by transcriptional regulation of the apoptotic machinery. Curr Opin Cell Biol 2003;15:732-7.
83. Deveraux QL, Reed JC. IAP family proteins-Suppressors of apoptosis. Genes Dev 1999;13:239-52.
84. Catz SD, Johnson JL. Transcriptional regulation of BCL-2 by nuclear factor kappa B and its significance in prostate cancer. Oncogene 2001;20:7342-51.
85. Chen C, Edelstein LC, Gelinas C. The Rel/NF-kappa B family directly activates expression of the apoptosis inhibitor Bcl-x(L). Mol Cell Biol 2000;20:2687-95.
86. Zong WX, Edelstein LC, Chen C, et al. The prosurvival BCL-2 homolog Bfl-1/A1 is a direct transcriptional target of NF-kappa B that blocks TNF alpha-induced apoptosis. Genes Dev 1999;13:382-7.
87. Stehlik C, de Martin R, Kumabashiri I, et al. Nuclear factor (NF)-kappaB-regulated X-chromosome-linked IAP gene expression protects endothelial cells from tumor necrosis factor alpha-induced apoptosis. J Exp Med 1998;188:211-6.
88. Wang CY, Mayo MW, Korneluk RG, et al. NF-kappa B anti apoptosis: Induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation. Science 1998;281:1680-3.
89. Bernard D, Quatannens B, Vandenbunder B, et al. Rel/NF-kappa B transcription factors protect against tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL)- induced apoptosis by up-regulating the TRAIL decoy receptor DcR1. J Biol Chem 2001;276:27322-8.
90. Micheau O, Lens S, Gaide O, et al. NF-kappa B signals induce the expression of c-FLIP. Mol Cell Biol 2001;21:5299-305.
91. Ravi R, Bedi GC, Engstrom LW, et al. Regulation of death receptor expression and TRAIL/Apo2L-induced apoptosis by NF-kappa B. Nat Cell Biol 2001;3:409-16.
92. Romeo G, Fiorucci G, Chiantore MV, et al. IRF-1 as a negative regulator of cell proliferation. J Interferon Cytokine Res 2002;22:39-47.
93. Sanceau J, Hiscott J, Delattre O, et al. IFN-beta induces serine phosphorylation of Stat-1 in Ewing's sarcoma cells and mediates apoptosis via induction of IRF-1 and activation of caspase-7. Oncogene 2000;19:3372-83.
94. Tomita Y, Bilim V, Hara N, et al. Role of IRF-1 and caspase-7 in IFN-gamma enhancement of Fas-mediated apoptosis in ACHN renal cell carcinoma cells. Int J Cancer 2003;104:400-8.
95. Jain N, Gupta S, Sudhakar C, et al. Role of p73 in regulating human caspase-1 gene transcription induced by interferon-{gamma} and cisplatin. J Biol Chem 2005;280:36664-73.
96. Ruiz-Ruiz C, Ruiz de Almodovar C, Rodriguez A, et al. The up-regulation of human caspase-8 by interferon-gamma in breast tumor cells requires the induction and action of the transcription factor interferon regulatory factor-1. J Biol Chem 2004;279:19712-20.
97. Stang MT, Armstrong MJ, Watson GA, et al. Interferon regulatory factor-1-induced apoptosis mediated by a ligand-independent Fas-associated death domain pathway in breast cancer cells. Oncogene 2007;26:6420-30.
98. Papageorgiou A, Dinney CP, McConkey DJ. Interferon-alpha induces TRAIL expression and cell death via an IRF-1-dependent mechanism in human bladder cancer cells. Cancer Biol Ther 2007;6:872-9.
99. Pizzoferrato E, Liu Y, Gambotto A, et al. Ectopic expression of interferon regulatory factor-1 promotes human breast cancer cell death and results in reduced expression of survivin. Cancer Res 2004;64:8381-8.
100. Barry SP, Townsend PA, Latchman DS, et al. Role of the JAK-STAT pathway in myocardial injury. Trends Mol Med 2007;13:82-9.
101. Battle TE, Frank DA. The role of STATs in apoptosis. Curr Mol Med 2002;2:381-92.
102. Hartman SE, Bertone P, Nath AK, et al. Global changes in STAT target selection and transcription regulation upon interferon treatments. Genes Dev 2005;19:2953-68.
103. Fujio Y, Kunisada K, Hirota H, et al. Signals through gp130 up regulate Bcl-x gene expression via STAT1-binding cis-element in cardiac myocytes. J Clin Invest 1997;99:2898-905.
104. Stephanou A, Brar BK, Knight RA, et al. Opposing actions of STAT-1 and STAT-3 on the BCL-2 and Bcl-x promoters. Cell Death Differ 2000;7:329-30.
105. Stephanou A, Scarabelli TM, Brar BK, et al. Induction of apoptosis and Fas receptor/Fas ligand expression by ischemia/reperfusion in cardiac myocytes requires serine 727 of the STAT-1 transcription factor but not tyrosine 701. J Biol Chem 2001;276:28340-7.
106. Shin EC, Ahn JM, Kim CH, et al. IFN-gamma induces cell death in human hepatoma cells through a TRAIL/death receptor-mediated apoptotic pathway. Int J Cancer 2001;93:262-8.
107. Stephanou A, Brar BK, Scarabelli TM, et al. Ischemia-induced STAT-1 expression and activation play a critical role in cardio myocyte apoptosis. J Biol Chem 2000;275:10002-8.
108. Ossina NK, Cannas A, Powers VC, et al. Interferon-gammamodulates a p53-independent apoptotic pathway and apoptosis-related gene expression. J Biol Chem 1997;272:16351-7.
109. Oritani K, Tomiyama Y, Kincade PW, et al. Both Stat3-activation and Stat3-independent BCL2 down regulation are important for interleukin-6-induced apoptosis of 1A9-Mcells. Blood 1999;93:1346-54.
110. Burke WM, Jin X, Lin HJ, et al. Inhibition of constitutively active Stat3 suppresses growth of human ovarian and breast cancer cells. Oncogene 2001;20:7925-34.
111. Shen Y, Devgan G, Darnell JE Jr., et al. Constitutively activated Stat3 protects fibroblasts from serum withdrawal and UV-induced apoptosis and antagonizes the pro apoptotic effects of activated Stat1. Proc Natl Acad Sci USA 2001;98:1543-8.
112. Epling-Burnette PK, Liu JH, Catlett-Falcone R, et al. Inhibition of STAT3 signaling leads to apoptosis of leukemic large granular lymphocytes and decreased Mcl-1 expression. J Clin Invest 2001;107:351-62.
113. Nielsen M, Kaestel CG, Eriksen KW, et al. Inhibition of constitutively activated Stat3 correlates with altered BCL-2/Bax expression and induction of apoptosis in mycosis fungoides tumor cells. Leukemia 1999;13:735-8.
114. Haga S, Terui K, Zhang HQ, et al. Stat3 protects against Fas-induced liver injury by redox-dependent and -independent mechanisms. J Clin Invest 2003;112:989-98.
115. Socolovsky M, Fallon AE, Wang S, et al. Fetal anemia and apoptosis of red cell progenitors in Stat5a-/-5b-/- mice: A direct role for Stat5 in Bcl-X(L) induction. Cell 1999;98:181-91.
116. Burgering BM, Medema RH. Decisions on life and death: FOXO Forkhead transcription factors are in command when PKB/Akt is off duty. J Leukoc Biol 2003;73:689-701.
117. Myatt SS, Lam EW. The emerging roles of Forkhead box (Fox) proteins in cancer. Nat Rev Cancer 2007;7:847-59.
118. Brunet A, Bonni A, Zigmond MJ, et al. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 1999;96:857-68.
119. Modur V, Nagarajan R, Evers BM, et al. FOX Oproteins regulate tumor necrosis factor related apoptosis inducing ligand expression. Implications for PTEN mutation in prostate cancer. J Biol Chem 2002;277:47928-37.
120. Rokudai S, Fujita N, Kitahara O, et al. Involvement of FKHR-dependent TRADD expression in chemotherapeutic drug-induced apoptosis. Mol Cell Biol 2002;22:8695-708.
121. You H, Pellegrini M, Tsuchihara K, et al. FOXO3a-dependent regulation of Puma in response to cytokine/growth factor withdrawal. J Exp Med 2006;203:1657-63.
122. Dijkers PF, Medema RH, Lammers JW, et al. Expression of the pro-apoptotic BCL-2 family member Bim is regulated by the Forkhead transcription factor FKHR-L1. Curr Biol 2000;10:1201-4.
123. Stahl M, Dijkers PF, Kops GJ, et al. The Forkhead transcription factor FoxO regulates transcription of p27Kip1 and Bim in response to IL-2. J Immunol 2002;168:5024-31.
124. Tang TT, Dowbenko D, Jackson A, et al. The Forkhead transcription factor AFX activates apoptosis by induction of the BCL-6 transcriptional repressor. J Biol Chem 2002;277:14255-65.
125. Bouchard C, Lee S, Paulus-Hock V, et al. FoxO transcription factors suppress Mycdriven lymphomagenesis via direct activation of Arf. Genes Dev 2007;21:2775-87.
126. Lei H, Juan AH, Kim MS, et al. Identification of a Hoxc8-regulated transcriptional network in mouse embryo fibroblast cells. Proc Natl Acad Sci USA 2006;103:10305-9.
127. Conradt B, Horvitz HR. The C. elegans protein EGL-1 is required for programmed cell death and interacts with the BCL-2-like protein CED-9. Cell 1998;93:519-29.
128. Liu H, Strauss TJ, Potts MB, et al. Direct regulation of egl-1 and of programmed cell death by the Hox protein MAB-5 and by CEH-20, a C. elegans homolog of Pbx1. Development 2006;133:641-50.
129. Kumar S, Cakouros D. Transcriptional control of the core cell-death machinery. Trends Biochem Sci 2004;29:193-9.
130. Lohmann I, McGinnis N, Bodmer M, et al. The Drosophila Hox gene deformed sculpts head morphology via direct regulation of the apoptosis activator reaper. Cell 2002;110:457-66.
131. Bello BC, Hirth F, Gould AP. A pulse of the Drosophila Hox protein Abdominal-A schedules the end of neural proliferation via neuro blast apoptosis. Neuron 2003;37:209-19.
132. Morgan R, Nalliah A, Morsi El-Kadi AS. FLASH, a component of the FAS-CAPSASE8 apoptotic pathway, is directly regulated by Hoxb4 in the notochord. Dev Biol 2004;265:105-12.
133. Shimamoto T, Nakamura S, Bollekens J, et al. Inhibition of DLX-7 homeobox gene causes decreased expression of GATA-1 and c-myc genes and apoptosis. Proc Natl Acad Sci USA 1997;94:3245-9.
134. Raman V, Martensen SA, Reisman D, et al. Compromised HOXA5 function can limit p53 expression in human breast tumours. Nature 2000;405:974-8.
135. Liu DX, Lobie PE. Transcriptional activation of p53 by Pitx1. Cell Death Differ 2007;14:1893-907.
136. Moucadel V, Totaro MS, Dell CD, et al. The homeobox gene Cdx1 belongs to the p53- p21(WAF)-BCL-2 network in intestinal epithelial cells. Biochem Biophys Res Commun 2002;297:607-15.
137. Heckman CA, Mehew JW, Ying GG, et al. A-Myb up-regulates BCL-2 through a Cdx binding site in t(14;18) lymphoma cells. J Biol Chem 2000;275:6499-508.
138. Nieto MA. The snail super family of zinc-finger transcription factors. Nat Rev Mol Cell Biol 2002;3:155-66.
139. Tribulo C, Aybar MJ, Sanchez SS, et al.A balance between the anti-apoptotic activity of Slug and the apoptotic activity of msx1 is required for the proper development of the neural crest. Dev Biol 2004;275:325-42.
140. Inukai T, Inoue A, Kurosawa H, et al. SLUG, a ces-1-related zinc finger transcription factor gene with antiapoptotic activity, is a downstream target of the E2A-HLF oncoprotein. Mol Cell 1999;4:343-52.
141. Newkirk KM, Mackenzie DA, Bakaletz AP, et al. Microarray analysis demonstrates a role for slug in epidermal homeostasis. J Invest Dermatol 2008;128:361-9.